Cat.#: ASSD-127
| Description | Fluorescent H3 histamine receptor antagonist (apparent KD values are 7.09, 6.55 and 5.71 for H3, H1 and H2 receptors respectively). Also antagonizes the activity of Histamine, a H1 agonist. Displays no intrinsic activity. |
| Size | 50 μg |
| Applications | For imaging at H3, H2 and H1 receptors use solutions up to 100 nM. |
| Molecule Weight | 848.5 |
| Purity | >95% |
| Solubility | Soluble in DMSO |
| Excitation | 633 nm |
| Emission | 650 nm |
| Storage | Store at -20° C |
| Shipping | Shipped at 4°C |
| Important | We strongly recommend storing this product away from light and briefly sonicating the sample when using to ensure it is fully dissolved and the solution is homogeneous. However, we do not recommend using the product after subjecting it to repetitive freeze-thaw cycles. |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ASSD-128 | Fluorescent M3 antagonist [pirenzepine] (AC128) | 50 μg | inquiry |
| ASSD-210 | 7-Amino-4-methyl-3-coumarinacetic acid N-succinimidyl ester (AC210) | 5 mg | inquiry |
| ASSD-117 | Annexin V-PE Apoptosis Staining / Detection Kit (AC117) | 1 kit, 100 tests | inquiry |
| ASSD-142 | Methoxy-X04 (AC142) | 10 mg, 50 mg | inquiry |
| ASSD-114 | Acridine Orange hydrochloride (AC114) | 50 mg | inquiry |
| ASSD-187 | Quinaldine Red (AC187) | 5 g, 25 g, 100 g, 250 g | inquiry |
| ASSD-207 | NBD-X acid (AC207) | 1 g | inquiry |
| ASSD-190 | Chrysamine G Disodium Salt (AC190) | 10 mg, 25 mg | inquiry |
| ASSD-194 | 7-(Diethylamino)coumarin-3-carboxylic acid (AC194) | 100 mg | inquiry |
| ASSD-201 | Fluoresceinamine Hydrochloride Isomer 1 (AC201) | 2 g | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.